Imagion Biosystems Limited (ASX:IBX)
0.0210
+0.0010 (5.00%)
At close: Mar 27, 2026
Imagion Biosystems Market Cap
Imagion Biosystems has a market cap or net worth of 10.3 million as of March 27, 2026. Its market cap has increased by 219.80% in one year.
Market Cap
10.30M
Enterprise Value
11.15M
Revenue
73.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 10.30M, a decrease of -68.45%. That is a compound annual growth rate of -12.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 10.30M | -15.23% |
| Dec 31, 2025 | 12.15M | 162.45% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 878.74M |
| Healius | 417.53M |
| Australian Clinical Labs | 380.25M |
| Monash IVF Group | 253.26M |
| Rhythm Biosciences | 67.28M |
| Cryosite | 56.13M |
| INOVIQ | 46.46M |
| Microba Life Sciences | 42.63M |